Envisioning the Future of Analytical Development for Gene Therapies

by Megan Pease | February 16, 2022

Robotic Arm -Virus-extended-1141367276-2000x1200

As therapeutic approaches evolve, the testing and characterization methods for viral vector manufacturing need innovation to support these increasingly complex modalities. Like traditional therapeutics, testing is used to confirm product identity, purity, potency, and safety.

Differences in viral vector manufacturing require new approaches to testing and characterization. The shelf-life and quantity of material produced in one batch is limited compared to traditional biologics. By utilizing molecular-based methods of testing instead of traditional culture-based methods, the time to result and volume required for testing can be greatly reduced. Identifying relevant quality attributes and proper assay controls is necessary to confirm product identity.

Innovative analytical approaches to viral vector processing will consider risk in both raw materials and manufacturing methods. Utilizing quality by design approaches throughout the development process and leveraging templated manufacturing processes will help to implement and define assays for testing prior to the validation process. Aiming for a defined, templated manufacturing process with platform assays can streamline the production process, and ultimately ensure safe and well-characterized products for patients.

Read the full article: “Envisioning the Future of Analytical Development for Gene Therapies

[starbox id=”MeganPease”]

Related Posts

Strengthening the CDMO-Sponsor Partnership with Improved Data Sharing and Collaboration

Collaboration between biomanufacturers and CDMOs often experiences challenges with data sharing. This presentation highlights the management of heterogenous...

Curious to learn more on PAT, Raman Spectroscopy, and Chemometrics?

Are you curious about Process Analytical Technologies (PAT), Raman spectroscopy, chemometrics and Raman applications in bioprocessing? Watch this...

What to consider for a modular facility with closed processing

The biopharmaceutical industry trends towards new product classes and smaller batch sizes drives even a greater need for…

Watch on Demand! Advance Scientific Innovation with M Lab™ Collaboration Centers Panel Discussion

Join us for this panel discussion to discover how a large global network of scientific experts, innovative technologies,...

Breaking perceptions of TFF in gene therapy manufacturing

The tangential flow filtration (TFF) unit operation in viral vector manufacturing is a critical step on the path…

Watch on Demand! 4th Annual Virtual Biotech Startup Symposium

We invite you to the 4th Annual Biotech Start-up Symposium, a free, two-day event to help Biotech Start-ups...

Scroll to Top